托法替布治疗溃疡性结肠炎：一种有前景的治疗选择。
Tofacitinib for ulcerative colitis: A promising treatment option.
机构信息
Department of Laboratory Medicine, Beijing Xiaotangshan Hospital, Beijing 102211, China.
Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
出版信息
World J Gastroenterol. 2024 Oct 28;30(40):4386-4392. doi: 10.3748/wjg.v30.i40.4386.
A single center retrospective clinical study revealed the efficacy and safety of tofacitinib in the treatment of ulcerative colitis (UC). This study has clinical reference value but also has some limitations. Previous studies, including this clinical trial, have shown that tofacitinib could be a promising treatment option for UC, but further clinical research is required to prove this point.
一项单中心回顾性临床研究揭示了托法替尼治疗溃疡性结肠炎（UC）的疗效和安全性。本研究具有临床参考价值，但也存在一定局限性。既往研究，包括本临床试验，均表明托法替尼可能是 UC 的一种有前途的治疗选择，但需要进一步的临床研究来证实这一点。
Zotero 插件